GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Barak Investment House Ltd (XTAE:BARI) » Definitions » Growth Rank

Barak Investment House (XTAE:BARI) Growth Rank : 9 (As of May. 13, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Barak Investment House Growth Rank?

Barak Investment House has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Competitive Comparison of Barak Investment House's Growth Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Barak Investment House's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Barak Investment House's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Barak Investment House's Growth Rank distribution charts can be found below:

* The bar in red indicates where Barak Investment House's Growth Rank falls into.



Barak Investment House Growth Rank Related Terms

Thank you for viewing the detailed overview of Barak Investment House's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Barak Investment House (XTAE:BARI) Business Description

Traded in Other Exchanges
N/A
Address
Jabotinsky Street 7, Ramat Gan, ISR, 52520
Panaxia Labs Israel Ltd is engaged in the manufacture and distribution of medical cannabis products. The firm offers a wide range of products comprising oral tablets, sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches.

Barak Investment House (XTAE:BARI) Headlines

No Headlines